Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPC1 | O15118 | 2/20 | 0.33 |
| ▸ | RAB9A | P51151 | 2/20 | 0.33 |
| ▸ | HPGD | P15428 | 1/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
| ▸ | ERN1 | O75460 | 1/20 | 0.32 |
| ▸ | TSHR | P16473 | 1/20 | 0.32 |
| ▸ | AHR | P35869 | 2/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12478321 | 0.82 | TSHR (0.41) | TSHR | |
| SCHEMBL23648094 | 0.82 | TSHR (0.41) | ERN1TSHRAHR | |
| SCHEMBL29363756 | 0.75 | PDK2 (0.37) | NPC1RAB9AHPGDSMN1; SMN2ERN1 | |
| SCHEMBL28901856 | 0.75 | ALDH1A1 (0.41) | HPGDSMN1; SMN2ERN1TSHRAHR | |
| SCHEMBL29429741 | 0.75 | TSHR (0.35) | NPC1RAB9AHPGDSMN1; SMN2ERN1 | |
| SCHEMBL29363049 | 0.75 | ALDH1A1 (0.41) | HPGDSMN1; SMN2ERN1TSHRAHR | |
| SCHEMBL29920955 | 0.75 | MAPT (0.37) | SMN1; SMN2 | |
| SCHEMBL263907 | 0.75 | PDK2 (0.37) | NPC1RAB9AHPGDSMN1; SMN2ERN1 | |
| SCHEMBL22165559 | 0.75 | TSHR (0.35) | NPC1RAB9AHPGDSMN1; SMN2ERN1 | |
| SCHEMBL29948146 | 0.75 | AKR1B1 (0.36) | NPC1RAB9AHPGDSMN1; SMN2ERN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 59 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2822941-A1 | BENZODIOXANES IN COMBINATION WITH OTHER ACTIVES FOR INHIBITING LEUKOTRIENE PRODUCTION | Boehringer Ingelheim International GmbH (DE) | 2015-01-14 | — | — | EP | claimed |
| WO-2013131901-A1 | BENZODIOXANES IN COMBINATION WITH OTHER ACTIVES FOR INHIBITING LEUKOTRIENE PRODUCTION | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2013-09-12 | — | — | WO | claimed |
| CN-118084840-B | Organic compound, organic electroluminescent device and electronic device | SHAANXI LIGHTE OPTOELECTRONICS MATERIAL Co.,Ltd. (CN) | 2026-05-26 | — | — | CN | disclosed |
| US-20260059997-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2026-02-26 | — | — | US | disclosed |
| US-12312342-B2 | Compound and organic light emitting device comprising same | LG CHEM, LTD. (KR) | 2025-05-27 | — | — | US | disclosed |
| CN-114096535-B | Heterocyclic compound, organic light-emitting element, composition for use in the same, and method for producing the same | LT素材株式会社 | 2025-03-07 | — | — | CN | disclosed |
| CN-115551838-B | Novel compound and organic light emitting device using the same | 株式会社LG化学 | 2024-11-26 | — | — | CN | disclosed |
| CN-115785077-B | Compound for organic photoelectric device, composition for organic photoelectric device, and display device | 三星SDI株式会社 | 2024-11-22 | — | — | CN | disclosed |
| US-12108661-B2 | Compound for organic electric element, organic electric element comprising the same, and electronic device thereof | DUK SAN NEOLUX CO., LTD. (KR) | 2024-10-01 | — | — | US | disclosed |
| US-12018022-B2 | Heterocyclic compound, organic light emitting diode comprising same, composition for organic layer of organic light emitting diode, and method for manufacturing organic light emitting diode | LT MATERIALS CO., LTD. (KR) | 2024-06-25 | — | — | US | disclosed |
| US-12018022-B2 | Heterocyclic compound, organic light emitting diode comprising same, composition for organic layer of organic light emitting diode, and method for manufacturing organic light emitting diode | LT MATERIALS CO., LTD. (KR) | 2024-06-25 | — | — | US | disclosed |
| WO-2020122576-A1 | HETEROCYCLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME, METHOD FOR MANUFACTURING SAME, AND COMPOSITION FOR ORGANIC MATERIAL LAYER | 엘티소재주식회사 | 2020-06-18 | — | — | WO | disclosed |
| WO-2020122576-A1 | HETEROCYCLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME, METHOD FOR MANUFACTURING SAME, AND COMPOSITION FOR ORGANIC MATERIAL LAYER | 엘티소재주식회사 | 2020-06-18 | — | — | WO | disclosed |
| EP-3087155-A1 | CONTROL OF SUSTAINED CASING PRESSURE IN WELLBORE ANNULI | Albemarle Corporation (US) | 2016-11-02 | — | — | EP | disclosed |
| US-20160289527-A1 | CONTROL OF SUSTAINED CASING PRESSURE IN WELLBORE ANNULI | ALBEMARLE CORP (US) | 2016-10-06 | — | — | US | disclosed |
| WO-2015100004-A1 | CONTROL OF SUSTAINED CASING PRESSURE IN WELLBORE ANNULI | ALBEMARLE CORPORATION (US) | 2015-07-02 | — | — | WO | disclosed |
| US-9051311-B2 | Sulfamide sodium channel inhibitors | AMGEN INC. (US) | 2015-06-09 | — | — | US | disclosed |
| WO-2013134518-A1 | SULFAMIDE SODIUM CHANNEL INHIBITORS | AMGEN INC. (US) | 2013-09-12 | — | — | WO | disclosed |
| EP-2396301-A2 | SMALL MOLECULE BRADYKININ B1 RECEPTOR ANTAGONISTS | Jerini AG (DE) | 2011-12-21 | — | — | EP | disclosed |
| WO-2010091876-A2 | SMALL MOLECULE BRADYKININ B1 RECEPTOR ANTAGONISTS | JERINI AG (DE) | 2010-08-19 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12018022-B2 | Heterocyclic compound, organic light emitting diode comprising same, composition for organic layer of organic light emitting diode, and method for manufacturing organic light emitting diode | ODC1, AOX1, CYP1B1 | NPC1 1924/4885RAB9A 3450/4885HPGD 410/4885 |
| US-12108661-B2 | Compound for organic electric element, organic electric element comprising the same, and electronic device thereof | PIEZO1, LEF1, ELP1 | NPC1 2510/4885RAB9A 3227/4885HPGD 4431/4885 |
| US-12312342-B2 | Compound and organic light emitting device comprising same | CRY1, CRY2, PER2 | NPC1 1073/4885RAB9A 2219/4885HPGD 2653/4885 |
| US-20260059997-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | LBR, GLRB, GLRA1 | NPC1 2509/4885RAB9A 1475/4885HPGD 4423/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.